HCW Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of HCW Biologics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-04-01 | $-0.30 | $-0.14 | -114.3 % |
Q3 | 2023-11-14 | $-0.14 | $-0.13 | -7.69 % |
Q2 | 2023-08-11 | $-0.12 | $-0.15 | 20.0 % |
Q1 | 2023-05-09 | $-0.14 | $-0.14 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2024-04-01 | $560.36K | $900.00K | -37.7 % |
Q3 | 2023-11-14 | $853.10K | $300.00K | 184.4 % |
Q1 | 2023-05-09 | $41.88K | $1.15M | -96.4 % |
HCW Biologics (HCWB) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.10, which missed the estimate of $0.00.
The Actual Revenue was $426.4K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.